NDI-5033

N/A

Report date: 2023/02/21 16:48:48
NME

Base Information

Drug NameNDI-5033
Drug Alias NameNDI-5033
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsDiabetes Insipidus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEmory UniversityNephroDI Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEmory University
Inactive CompaniesN/A
Active IndicationsDiabetes Insipidus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A